Han RY - Search Results

1

Huanglian Jiedu plaster ameliorated X-ray-induced radiation dermatitis injury by inhibiting HMGB1-mediated macrophage-inflammatory interaction.

Wang J, Xie KH, Ren W, Han RY, Xiao LH, Yu J, Tan RZ, Wang L, Liao DZ. Wang J, et al. Among authors: han ry. J Ethnopharmacol. 2023 Feb 10;302(Pt B):115917. doi: 10.1016/j.jep.2022.115917. Epub 2022 Nov 19. J Ethnopharmacol. 2023. PMID: 36414215 Free article.

2

Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway.

Xie KH, Liu XH, Jia J, Zhong X, Han RY, Tan RZ, Wang L. Xie KH, et al. Among authors: han ry. Int Immunopharmacol. 2022 Nov;112:109247. doi: 10.1016/j.intimp.2022.109247. Epub 2022 Sep 22. Int Immunopharmacol. 2022. PMID: 36155281 Free article.

3

Podocarpusflavone alleviated renal fibrosis in obstructive nephropathy by inhibiting Fyn/Stat3 signaling pathway.

Zhu B, Han R, Ni Y, Guo H, Liu X, Li J, Wang L. Zhu B, et al. J Nat Med. 2023 Jun;77(3):464-475. doi: 10.1007/s11418-023-01685-y. Epub 2023 Mar 8. J Nat Med. 2023. PMID: 36884159

4

Hederagenin ameliorates renal fibrosis in chronic kidney disease through blocking ISG15 regulated JAK/STAT signaling.

Jia J, Xu LH, Deng C, Zhong X, Xie KH, Han RY, Su HW, Tan RZ, Wang L. Jia J, et al. Among authors: han ry. Int Immunopharmacol. 2023 May;118:110122. doi: 10.1016/j.intimp.2023.110122. Epub 2023 Apr 5. Int Immunopharmacol. 2023. PMID: 37023701

5

Macrophages mediate psoriasis via Mincle-dependent mechanism in mice.

Tan RZ, Zhong X, Han RY, Xie KH, Jia J, Yang Y, Cheng M, Yang CY, Lan HY, Wang L. Tan RZ, et al. Among authors: han ry. Cell Death Discov. 2023 Apr 28;9(1):140. doi: 10.1038/s41420-023-01444-8. Cell Death Discov. 2023. PMID: 37117184 Free PMC article.

6

Serum untargeted metabolomics analysis of uremic pruritus in patients with various etiologies.

Tan RZ, Xu LH, Li T, Zhao WJ, Han RY, Zhang Q, Su HW, Wang L, Liu J. Tan RZ, et al. Among authors: han ry. Int Immunopharmacol. 2024 Dec 25;143(Pt 3):113563. doi: 10.1016/j.intimp.2024.113563. Epub 2024 Nov 12. Int Immunopharmacol. 2024. PMID: 39527886

7

Lenvatinib, sintilimab combined interventional treatment vs bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma.

Han RY, Gan LJ, Lang MR, Ren SH, Liu DM, Li GT, Liu YY, Tian XD, Zhu KW, Sun LY, Chen L, Song TQ. Han RY, et al. World J Gastroenterol. 2024 Nov 21;30(43):4620-4635. doi: 10.3748/wjg.v30.i43.4620. World J Gastroenterol. 2024. PMID: 39575400 Free PMC article.

8

CST3 alleviates retinal vascular leakage by regulating the Rap1 signaling pathway.

Yang H, Han RY, Gong RW, Zhang YJ, Yang SS, Xu GZ, Liu W. Yang H, et al. Among authors: han ry. Exp Eye Res. 2024 Oct;247:110042. doi: 10.1016/j.exer.2024.110042. Epub 2024 Aug 13. Exp Eye Res. 2024. PMID: 39147193

9

Trends and cross-country inequalities in the global burden of osteoarthritis, 1990-2019: A population-based study.

Cao F, Xu Z, Li XX, Fu ZY, Han RY, Zhang JL, Wang P, Hou S, Pan HF. Cao F, et al. Among authors: han ry. Ageing Res Rev. 2024 Aug;99:102382. doi: 10.1016/j.arr.2024.102382. Epub 2024 Jun 23. Ageing Res Rev. 2024. PMID: 38917934 Review.

10

Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping.

Wang P, Li H, Zhu M, Han RY, Guo S, Han R. Wang P, et al. Among authors: han ry. Mol Ther Methods Clin Dev. 2022 Dec 2;28:40-50. doi: 10.1016/j.omtm.2022.11.010. eCollection 2023 Mar 9. Mol Ther Methods Clin Dev. 2022. PMID: 36588820 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters